Trials / Completed
CompletedNCT06644001
Bacillus Coagulans Effect on Gastrointestinal Function in Healthy Adults.
Impact of Heyndrickxia (Bacillus) Coagulans Probiotic on Gastrointestinal Function in Healthy Adults: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- Kerry Group P.L.C · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
A single centre, double-blind, placebo-controlled study to evaluate the effect of the consumption of Bacillus coagulans at a daily dose of 1 x 10⁹ CFU on bowel habits, intestinal microbiota and gastrointestinal symptoms in healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Bacillus coagulans GBI-30,6086 (BC GBI-30) | 2g powder/sachet, consists of bacillus coagulans at a dose of 1x10\^9 CFU, taken once daily before a meal. |
| DIETARY_SUPPLEMENT | Placebo | 2g powder/sachet, consists of maltodextrin only, taken once daily before a meal. |
Timeline
- Start date
- 2021-07-01
- Primary completion
- 2021-10-30
- Completion
- 2021-10-30
- First posted
- 2024-10-16
- Last updated
- 2024-10-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06644001. Inclusion in this directory is not an endorsement.